Published in Oncogene on November 08, 2001
SelTarbase, a database of human mononucleotide-microsatellite mutations and their potential impact to tumorigenesis and immunology. Nucleic Acids Res (2009) 1.02
Comprehensive genome- and transcriptome-wide analyses of mutations associated with microsatellite instability in Korean gastric cancers. Genome Res (2013) 0.97
Screening for microsatellite instability identifies frequent 3'-untranslated region mutation of the RB1-inducible coiled-coil 1 gene in colon tumors. PLoS One (2009) 0.88
Deletion in a (T)8 microsatellite abrogates expression regulation by 3'-UTR. Nucleic Acids Res (2003) 0.88
Upstream mononucleotide A-repeats play a cis-regulatory role in mammals through the DICER1 and Ago proteins. Nucleic Acids Res (2013) 0.77
Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer. Lancet (2000) 5.04
BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines. Cancer Res (1997) 2.77
BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet (2004) 2.75
Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands. Gut (2002) 2.31
Determination of the replication error phenotype in human tumors without the requirement for matching normal DNA by analysis of mononucleotide repeat microsatellites. Genes Chromosomes Cancer (1998) 2.09
KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression. Oncogene (2006) 2.07
The human T-cell transcription factor-4 gene: structure, extensive characterization of alternative splicings, and mutational analysis in colorectal cancer cell lines. Cancer Res (2000) 1.77
Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1. J Virol (1991) 1.75
P53 alteration and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma. Clin Cancer Res (2001) 1.74
Evolution of instability at coding and non-coding repeat sequences in human MSI-H colorectal cancers. Hum Mol Genet (2001) 1.74
Ionic currents in mammalian fast skeletal muscle. J Physiol (1978) 1.72
Alternative genetic pathways in colorectal carcinogenesis. Proc Natl Acad Sci U S A (1997) 1.68
Extensive characterization of genetic alterations in a series of human colorectal cancer cell lines. Oncogene (2001) 1.64
p53 gene mutation, microsatellite instability and adjuvant chemotherapy: impact on survival of 388 patients with Dukes' C colon carcinoma. Oncology (2000) 1.52
Frequent alteration of DNA damage signalling and repair pathways in human colorectal cancers with microsatellite instability. Oncogene (2007) 1.50
Allelic profiles of mononucleotide repeat microsatellites in control individuals and in colorectal tumors with and without replication errors. Oncogene (1997) 1.47
Frequent frameshift mutations of the TCF-4 gene in colorectal cancers with microsatellite instability. Cancer Res (1999) 1.46
p53 and disease: when the guardian angel fails. Cell Death Differ (2006) 1.41
Ionic currents in slow twitch skeletal muscle in the rat. J Physiol (1980) 1.38
Guidelines for surveillance of individuals with constitutional mismatch repair-deficiency proposed by the European Consortium "Care for CMMR-D" (C4CMMR-D). J Med Genet (2014) 1.36
DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer. Br J Cancer (2006) 1.36
A polymorphism in the methylenetetrahydrofolate reductase gene predisposes to colorectal cancers with microsatellite instability. Gut (2002) 1.32
Relating genotype and phenotype in breast cancer: an analysis of the prognostic significance of amplification at eight different genes or loci and of p53 mutations. Cancer Res (2000) 1.30
Impact of p53 expression and microsatellite instability on stage III colon cancer disease-free survival in patients treated by 5-fluorouracil and leucovorin with or without oxaliplatin. Ann Oncol (2009) 1.29
Prognostic significance of TP53 gene mutation in 995 cases of colorectal carcinoma. Influence of tumour site, stage, adjuvant chemotherapy and type of mutation. Eur J Cancer (2000) 1.29
The internalization signal and the phosphorylation site of transferrin receptor are distinct from the main basolateral sorting information. EMBO J (1993) 1.27
Microsatellite instability occurs in distinct subtypes of pediatric but not adult central nervous system tumors. Cancer Res (2001) 1.23
Sequential expression of putative stem cell markers in gastric carcinogenesis. Br J Cancer (2011) 1.22
TCF-4 isoforms absent in TCF-4 mutated MSI-H colorectal cancer cells colocalize with nuclear CtBP and repress TCF-4-mediated transcription. Oncogene (2006) 1.17
Population-based study of prognostic factors in stage II colonic cancer. Br J Surg (2006) 1.16
Short direct repeats flanking deletions, and duplicating insertions in p53 gene in human cancers. Oncogene (1993) 1.15
Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer. Br J Cancer (2009) 1.14
Polymorphisms and probable lack of mutation in the WAF1-CIP1 gene in colorectal cancer. Oncogene (1995) 1.12
Comparison between the delayed outward current in slow and fast twitch skeletal muscle in the rat. J Physiol (1980) 1.10
p53 alterations are associated with improved prognosis in distal colonic carcinomas. Clin Cancer Res (1997) 1.09
Mutational analysis of the PTEN gene in gliomas: molecular and pathological correlations. Int J Cancer (1999) 1.09
Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas. Br J Cancer (1994) 1.08
Role of intracellular calcium and protein kinase C in the endocytosis of transferrin and insulin by HL60 cells. J Cell Biol (1986) 1.06
Inverse correlation between RER+ status and p53 mutation in colorectal cancer cell lines. Oncogene (1996) 1.06
Temperature-sensitive viral RNA expression in Moloney murine sarcoma virus ts110-infected cells. J Virol (1985) 1.05
Failure to complete adjuvant chemotherapy is associated with adverse survival in stage III colon cancer patients. Br J Cancer (2007) 1.05
Assessment of MLH1 promoter methylation in relation to gene expression requires specific analysis. Oncogene (2007) 1.04
Assignment of the TCF-4 gene (TCF7L2) to human chromosome band 10q25.3. Cytogenet Cell Genet (2000) 1.04
Microsatellite instability is a predictive marker for survival benefit from adjuvant chemotherapy in a population-based series of stage III colorectal carcinoma. Clin Colorectal Cancer (2001) 1.04
Use of immunoglobulins in the prevention of GvHD in a xenogeneic NOD/SCID/γc- mouse model. Bone Marrow Transplant (2011) 0.99
Ki-ras mutation type and the survival benefit from adjuvant chemotherapy in Dukes' C colorectal cancer. J Pathol (2001) 0.98
Infrequent microsatellite instability in oesophageal cancers. Br J Cancer (1997) 0.97
Concurrent hypermethylation of gene promoters is associated with a MSI-H phenotype and diploidy in gastric carcinomas. Eur J Cancer (2003) 0.97
Variable mutation frequencies in coding repeats of TCF-4 and other target genes in colon, gastric and endometrial carcinoma showing microsatellite instability. Oncogene (1999) 0.97
Prognostic significance of mutations to different structural and functional regions of the p53 gene in breast cancer. Clin Cancer Res (2000) 0.97
The expression of RUNX3 in colorectal cancer is associated with disease stage and patient outcome. Br J Cancer (2009) 0.96
Microsatellite instability as a molecular marker for very good survival in colorectal cancer patients receiving adjuvant chemotherapy. Gastroenterology (2001) 0.95
Identification of homozygous deletions at chromosome 16q23 in aflatoxin B1 exposed hepatocellular carcinoma. Oncogene (2001) 0.95
Internalization pathway of C3b receptors in human neutrophils and its transmodulation by chemoattractant receptors stimulation. Cell Regul (1991) 0.93
p53 from basic research to clinical applications. Crit Rev Oncog (1992) 0.93
Lack of somatic mutation in the coding sequence of SIAH1 in tumors hemizygous for this candidate tumor suppressor gene. Int J Cancer (2000) 0.92
No major contribution of TCF7L2 sequence variants to maturity onset of diabetes of the young (MODY) or neonatal diabetes mellitus in French white subjects. Diabetologia (2006) 0.92
Tumours with loss of MSH6 expression are MSI-H when screened with a pentaplex of five mononucleotide repeats. Br J Cancer (2010) 0.92
Temperature-sensitive splicing defect of ts110 Moloney murine sarcoma virus is virus encoded. J Virol (1986) 0.92
Predictive value of microsatellite instability for benefit from adjuvant fluorouracil chemotherapy in colorectal cancer. Gut (2006) 0.91
Relative efficiency of denaturing gradient gel electrophoresis and single strand conformation polymorphism in the detection of mutations in exons 5 to 8 of the p53 gene. Oncogene (1994) 0.91
Extent of transcription of mouse sarcoma-leukemia virus by RNA-directed DNA polymerase. Proc Natl Acad Sci U S A (1974) 0.90
Voltage clamp with double sucrose gap technique. External series resistance compensation. Biophys J (1976) 0.89
Can p53 alterations be used to predict tumour response to pre-operative chemo-radiotherapy in locally advanced rectal cancer? Radiother Oncol (2000) 0.89
Identification of serosal invasion and extramural venous invasion on review of Dukes' stage B colonic carcinomas and correlation with survival. Histopathology (2007) 0.89
A scorpion venom neurotoxin paralytic to insects that affects sodium current inactivation: purification, primary structure, and mode of action. Biochemistry (1990) 0.89
The gag-mos hybrid protein of ts110 Moloney murine sarcoma virus: variation of gene expression with temperature. Virology (1984) 0.89
Microsatellite instability and mutation analysis of candidate genes in urothelial cell carcinomas of upper urinary tract. Oncogene (2006) 0.88
Polymorphisms of the interleukin-6 gene promoter and abdominal aortic aneurysm. Eur J Vasc Endovasc Surg (2007) 0.88
Effects of actinomycin D, toyocamycin and cycloheximide on the synthesis of low-molecular-weight nuclear RNAs in HeLa cells. Eur J Biochem (1973) 0.88
Heme inhibits transferrin endocytosis in immature erythroid cells. Biochim Biophys Acta (1984) 0.87
Low expression of gamma-glutamyl hydrolase mRNA in primary colorectal cancer with the CpG island methylator phenotype. Br J Cancer (2008) 0.87
Voltage-clamp experiments in mammalian slow twitch skeletal muscle [proceedings]. J Physiol (1979) 0.87
Response to 5-fluorouracil of orthotopically xenografted human colon cancers with a microsatellite instability: influence of P53 status. Anticancer Res (2000) 0.87
Loss of heterozygosity on chromosome 9 and p16 (MTS1, CDKN2) gene mutations in esophageal cancers. Int J Cancer (1997) 0.86
Mutation of the transforming growth factor-beta type II receptor gene in right-sided colorectal cancer: relationship to clinicopathological features and genetic alterations. J Pathol (1998) 0.86
Polymorphisms of the matrix metalloproteinase 9 gene and abdominal aortic aneurysm. Br J Surg (2008) 0.86
Frequently elevated content of immunochemically defined wild-type p53 protein in colorectal adenomas. Oncogene (1993) 0.86
[Profile of p53 mutations and abnormal expression of P53 protein in 2 forms of esophageal cancer]. Gastroenterol Clin Biol (1996) 0.86
p53 abnormalities in adenocarcinoma of the gastric cardia and antrum. Mol Pathol (1999) 0.85
Frequent loss of heterozygosity on chromosome 9, and low incidence of mutations of cyclin-dependent kinase inhibitors p15 (MTS2) and p16 (MTS1) genes in gliomas. Oncogene (1995) 0.85
Voltage-clamp studies in rat fast skeletal muscle [proceedings]. J Physiol (1977) 0.85
Correlations between p53-protein accumulation, serum antibodies and gene mutation in colorectal cancer. Int J Cancer (1999) 0.85
Integrating next-generation sequencing into the diagnostic testing of inherited cancer predisposition. Clin Genet (2012) 0.84
Incidence of germ-line p53 mutations in patients with gliomas. Int J Cancer (1995) 0.83
Characterization of viral RNA in cells transformed by various isolates of Moloney murine sarcoma virus. J Gen Virol (1983) 0.83
Deep UV nano-microstructuring of substrates for surface plasmon resonance imaging. Nanotechnology (2011) 0.83
Gastric carcinomas with microsatellite instability: clinical features and mutations to the TGF-beta type II receptor, IGFII receptor, and BAX genes. J Pathol (1999) 0.83